Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer

SIMPLE SUMMARY: The study compares the effects on complete remission rate (CR) of a single dose of durvalumab/tremelimumab immediately after a single-cycle platinum and docetaxel as part of induction therapy for a controlled trial in head and neck cancer with chemotherapy alone from a historical col...

Descripción completa

Detalles Bibliográficos
Autores principales: Semrau, Sabine, Gostian, Antoniu-Oreste, Traxdorf, Maximilian, Eckstein, Markus, Rutzner, Sandra, von der Grün, Jens, Illmer, Thomas, Hautmann, Matthias, Klautke, Gunther, Laban, Simon, Brunner, Thomas, Tamaskovics, Bálint, Frey, Benjamin, Zhou, Jian-Guo, Geppert, Carol-Immanuel, Hartmann, Arndt, Balermpas, Panagiotis, Budach, Wilfried, Gaipl, Udo, Iro, Heinrich, Fietkau, Rainer, Hecht, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073509/
https://www.ncbi.nlm.nih.gov/pubmed/33921668
http://dx.doi.org/10.3390/cancers13081959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073509/
https://www.ncbi.nlm.nih.gov/pubmed/33921668
http://dx.doi.org/10.3390/cancers13081959

Ejemplares similares